Cell therapy to repair broken hearts

Canadian Journal of Cardiology

Volumn 14, Issue 5, 1998, Pages 735-744

  Li, Ren Ke ^a,b   Yau, Terrence M ^a   Sakai, Tetsuro ^a   Mickle, Donald A G ^a   Weisel, Richard D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Angiogenesis; Cell transplantation; Gene therapy; Heart failure; Heart junction

Indexed keywords

CELL PROLIFERATION; CELL TRANSFORMATION; CELL TRANSPLANTATION; FIBROBLAST; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; NONHUMAN; REVIEW;

ADULT; CELL TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; GENE THERAPY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; VENTRICULAR FUNCTION, LEFT;

EID: 0031834611     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Cecere R, Latter D, Chiu RC-J, Fitchett D. An integrated approach to the surgical management of Heart failure. Can J Cardiol 1995;11:407-14.
2. Massie B, Shah N. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703-12.
3. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs L, Capasso JM. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 1990,67:871-85.
4. Liu Y, Cigola E, Cheng W, et al. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 1995;73:771-87.
5. Goldstein MA, Claycomb WC, Schwartz A. DNA synthesis and mitosis in well differentiated cardiac myocytes. Science 1974;183:212-3.
6. Arnold JMO. Management of heart failure. In: Transer PH, ed. Heart Failure Montreal: Grosvenor House Press Inc, 1994:31-50.
7. Schmoeckel M, Mollert G, Shahmohammadi M, et al. Transgenic human decay accelerating factor makes normal pigs function as a concordant species. J Heart Lung Transplant 1997;16:758-64.
8. Diamond LE, McCurry KR, Martin MJ, et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 1996;61:1241-9.
9. Chiu RC. Dynamic cardiomyoplasty for heart failure. Br Heart J 1995;73:1-3.
10. Oh JH, Badhwar V, Chiu RC. Mechanisms of dynamic cardiomyoplasty: current concepts. J Cardiac Surg 1996;11:194-9.
11. Courtney JM, Forbes CD. Thrombosis on foreign surfaces. Br Med Bull 1994;50:966-81.
12. Burns GL. Infections associated with implanted blood pumps. Int J Artif Organs 1993;16:771-6.
13. Batista R, Santos J, Takeshita N, Bocchino L, Lima P, Cunha M. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 1996;11:96-7.
14. Batista RJ, Verde J, Nery P, et al. Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 1997;64:634-8.
15. Rumyantsev PP. Interrelations of the proliferation and differentiation processes during cardiac myogenesis and regeneration. Int Rev Cytol 1977;51:187-273.
16. Quaini F, Cigola E, Lagrasta C, et al. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res 1994;75:1050-63.
17. Slack JMW. Role of fibroblast growth factors as inducing agents in early embryonic development. Mol Reprod Dev 1994;39:118-24.
18. Cummins P. Fibroblast and transforming growth factor expression in the cardiac myocyte. Cardiovasc Res 1993;27:1150-4.
19. Cheng W, Reiss K, Kajstura J, Kowal K, Quaini F, Anversa P. Down-regulation of the IGF-I system parallels the attenuation in the proliferative capacity of rat ventricular myocytes during postnatal development. Lab Invest 1995;72:646-55.
20. Rappolee DA, Sturm KS, Behrendtsen O, Schultz GA, Pedersen RA, Werb Z. Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Gene Dev 1992;6:939-52.
21. Akhurst RJ, Lehnert SA, Faissner A, Duffie E. TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development 1990;108:645-56.
22. Muslin AJ, Williams LT. Well-defined growth factors promote cardiac development in axolotl mesodermal explants. Development 1991;146:242-5.
23. Reiss K, Cheng W, Ferber A, et al Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci USA 1996;93:8630-5.
24. Hanson MC, Fath KA, Alexander RW, Delafontaine P. Induction of cardiac insulin-like growth factor I gene expression in pressure overload hypertrophy. Am J Med Sci 1993;306:69-74.
25. 1 expression in rat ventricular cardiomyocytes. J Clin Invest 1994;94:1470-6.
26. Padua R, Kardami E. Increased basic fibroblast growth factor accumulation and distinct patterns of localization in isoproternol-induced cardiomyocyte injury. Growth Factor 1993;8:291-306.
27. Kardami E. Stimulation and inhibition of cardiac myocyte proliferation in vitro. Mol Cell Biochem 1990;92:129-35.
28. Soonpaa MH, Oberpriller JO, Oberpriller JC. Stimulation of DNA synthesis by PDGF in the Newt cardiac myocyte. J Mol Cell Cardiol 1992;24:1039-46.
29. Reiss K, Cheng W, Pierzchalski P, et al. Insulin-like growth factor-I receptor and its ligand regulate the reentry of adult ventricular myocytes into the cell cycle. Exp Cell Res 1997;235:198-209.
30. Ito H, Hiroe M, Hirata Y, et al. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993;87:1715-21.
31. Donath MY, Zapf J, Eppenberger-Eberhardt M, Froesch ER, Eppenberger HM. Insulin-like growth factor-1 stimulates myofibol development and decreases smooth muscle α-actin of adult cardiomyocytes Proc Natl Acad Sci USA 1994,91:1686-90.
32. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in messenger RNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 1992;262:H1861-6.
33. Bjarnason I, Jonsson S, Hardarson T. Mode of inheritance of hypertrophic cardiomyopathy in Iceland. Echocardiographic study. Br Heart J 1982;47:122-9.
34. Li R-K, Li G, Mickle DAG, et al. Over-expression of transforming growth factor beta1 and insulin-like gtowth factor-1 in patients with idiopathic hypertrophic cardiomyopathy. Circulation 1997;96:874-81.
35. Jackson T, Allard MF, Sreenan CM, Doss LK, Bishop SP, Swain JL Transgenic animals as a tool for studying the effect of the c-myc proto-oncogene on cardiac development. Mol Cell Biochem 1991;104:15-9.
36. Schneider MD, Payne PA, Ueno H, Perryman MB, Roberts R. Dissociated expression of c-myc and α-fos-related competence gene during cardiac myogenesis. Mol Cell Biol 1986;6:4140-3.
37. Jackson T, Allard MF, Sreenan CM, Doss LK, Bishop SP, Swam JL. The c-myc proto-oncogene regulate cardiac development in transgenic mice. Mol Cell Biol 1990;10:3709-16.
38. Saule S, Merigaud JP, AlMoustafa AEM, et al. Heart tumors specifically induced in young avian embryos by the v-myc oncogene. Proc Natl Acad Sci USA 1987;84:7982-6.
39. Thorburn A, Thorburn J, Chen S-Y, et al. HRas dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem 1993;268:2244-9.
40. Schneider JW, Gu W, Zhu L, Mahdavi V, Nadal-Ginard B. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Sicence 1994;264:1467-71.
41. Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoprotein. Science 1992;258:424-9.
42. Kirshenbaum LA, Schneider MD. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J Biol Chem 1995;270:7791-4.
43. Soonpaa MH, Koh GY, Pajak L, et al. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 1997;99:2644-54.
44. King RW, Jackson PK, Kirschner MW. Mitosis in transition. Cell 1994;79:563-71.
45. Katz EB, Steinhelper ME, Delcarpio JB, Daud AI, Claycomb WC, Field LJ. Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am J Physiol 1992;262:H1867-76.
46. Wright WE, Sassoon DA, Lin VK. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD1. Cell 1989;56:607-17.
47. Edmondson DG, Olson EN. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev 1989;3:628-40.
48. Braun T, Buschhausen-Denker G, Bober E, Tannich E, Arnold HH. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J 1989;8:701-9.
49. Rhodes SJ, Konieczny SF. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev 1989;3:2050-61.
50. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987;51:987-1000.
51. Tanji K, Sancho S, Miranda AF. Innervation of MyoD-converted human amniocytes and fibroblasts by fetal rodent spinal cord neurons. Neuromuscul Dis 1994;4:317-24.
52. Murry CE, Kay MA, Hauschka S, Schwartz SM. Can MyoD gene transfer induce muscle differentiation in the healing hearts? J Mol Cell Cardiol 1995;27:A2. (Abst)
53. Murry CE, Kay MA, Bartosek T, Hauschka SD, Schwartz SM. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J Clin Invest 1996;98:2209-17.
54. Eghbali M, Tomek R, Woods C, Bhambi B. Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor β. Proc Natl Acad Sci USA 1991;88:795-9
55. Koh GY, Kim SJ, Klug MG, Park K, Soonpaa MH, Field LJ. Targeted expression of transforming growth factor-beta1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest 1995;95:114-21.
56. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: Evidence for the "hibernating myocardium". J Am Coll Cardtol 1986;8:1467-70.
57. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collareral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-9.
58. Unger EF, Banai S, Shou M, et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994;266:H1588-95.
59. Lazarous DF, Scheinowitz M, Shou M, et al. Effects of chronic systemic adminstration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 1995;91:145-53.
60. Harada K, Grossman WF, Friedman M, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994;94:623-30.
61. Asahara T, Bauters C, Zheng L, et al. Synergistic effect of vascular endothelial growth factor and basic growth factor on angiogenesis in vivo. Circulation 1995;92:II365-71.
62. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401-3.
63. Whittaker P, Rakusan K, Kloner RA. Transmural channels can protect ischemic tissue. Assessment of long-term myocardial response to laser- and needle-made channels. Circulation 1996;93:143-52.
64. Gassler N, Wintzer HO, Stubbe HM, Wullbrand A, Helmchen U. Transmyocardial laser revascularization. Histological features in human nonresponder myocardium. Circulation 1997;95:371-5.
65. Krabatsch T, Schaper F, Leder C, Tulsner J, Thalmann U, Hetzer R. Histological findings after transmyocardial laser revascularization. J Card Surg 1996;11:326-31.
66. 2 laser. J Thorac Surg 1996;63:1275-83.
67. Whittaker P, Kloner RA, Przyklenk K. Laser-mediated transmural myocardial channels do not salvage acutely ischemic myocardium. J Am Coll Cardiol 1993;22:302-9.
68. Oberpriller JO, Oberpriller JC, Arefyeva AM, Mitashov VI, Carlson BM. Nuclear characteristics of cardiac myocytes following the proliferative response to mincing of the myocardium in adult newt, Notophthalmus vindescens. Cell Tissue Res 1988;253:619-24.
69. Swenson WM, Gale HH, Bancroft JH, Beattie Jr EJ, Alpert NR. Atrial myocardium transplanted in right ventricule: growth, histologic alterations and mechanical properties after 21 months. Ann Surg 1965;162:1039-45.
70. Torres A, Tucker DC. Effect of thyroid hormones on cardiac development in oculo. Am Physiol 1993;264:H244-51.
71. Jockusch H, Mehrke G, Fuchtbauer E. Beating heart muscle in a skeletal muscle bed. Exp Neurol 1983;81:749-55.
72. Fulmer RI, Cramer AT, Liebelt RA, Liebelt AG. Transplantation of cardiac tissue into the mouse ear. Am J Anat 1963;113:273-81.
73. Bishop SP, Anderson PG, Tucker DC. Morphological development of the rat heart growing in oculo in the absence of hemodynamic work load. Circ Res 1990;66:84-102
74. Jockusch H, Fuchtbauer E, Fuchtbauer A, et al. Long-term expression of isomyosins and myoendocrine functions in ectopic grafts of atrial tissue. Proc Natl Acad Sci USA 1998;83:7325-9.
75. Broadwell RD, Charlton HM, Ebert P, Hickey WF, Villegas JC, Wolf AL. Angiogenesis and blood-brain barrier in solid and dissociated cell grafts within the CNS. Prog Brain Res 1990;82:95-101.
76. Alberts B, Denenis B, Lewis J, Raff M, Roberts K, Watson JD. Differentiated cells and the maintenance of tissue: Quiescent stem cells: skeletal muscle. In: Anonymous Molecular Biology of the Cell. New York: Garland Publishing Inc, 1983:928-33.
77. Campion D. The satellite cell: A review. Int Rev Cytol 1984;87:225-51.
78. Marelli D, Deschene C, Al-Elfy M, Kao R, Chiu R. Cell transplantation for myocardial repair: An experimental approach. Cell Transplant 1992;1:383-90.
79. Koh GY, Klug MG, Soonpaa MH, Field LJ. Differentiation and long-term survival of C2C12 myoblast grafts in heart J Clin Invest 1993;92:1548-54.
80. Zibaitis A, Greentree D, Ma F, Marelli D, Duong M, Chiu R. Myocardial regeneration with satellite cell implantation. Transplant Proc 1994;26:3294.
81. Robinson SW, Cho PW, Levitsky HI, et al. Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblasts. Cell Transplant 1996;5:77-91.
82. Schultz E, Lipton BH. Skeletal muscle satellite cells: changes in proliferation potential as a function of age. Mech Ageing Dev 1982;20:377-83.
83. Gibson MC, Schultz E. The distribution of satellite cells and their relationship to specific fiber types in soleus and extensor digitorum longus muscles. Anat Rec 1982;202:329-37.
84. Kelly AM. Satellite cells and myofiber growth in the rat soleus and extensor digitorum longus muscle Dev Biol 1978;65:1-10.
85. Cantini AI, Massimino ML, Catani C. Gene transfer into satellite cell from regenerating muscle: bupivacaine allows beta-Gal transfection and expression in vitro and in vivo. In Vitro Cell Dev Biol 1994;30:131-3.
86. Henry RR, Abrams L, Nikoulina S, Ciaraldi TP. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects: comparison using human skeletal muscle cell cultures. Diabetes 1995;44:936-46.
87. Delcarpio JB, Lanson NA, Field LJ, Claycomb WC. Morphological characterization of cardiomyocytes isolated from a transplantable cardiac tumor derived from transgenic mouse atria (AT-1 cells). Circ Res 1991;69:1591-600.
88. Koh GY, Soonpaa MH, Klug MG, Field LJ. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol 1993;264:H1727-33.
89. Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994;264:98-101.
90. Li R-K, Zhang Z, Weisel RD, Mohabeer MK, Mickle DAG. Effect of donor age on contractility of transplanted rat cardiomyocytes. J Mol Cell Cardiol 1994;26:162A.
91. Li R-K, Mickle DAG, Weisel RD, Zhang J, Mohabeer MK. In vivo survival and function of transplanted rat cardiomyocytes. Circ Res 1996;78:283-8.
92. Koh GY, Soonpaa MH, Klug MG, Pride HP, Cooper BJ, Zipes DP. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dog. J Clin Invest 1995;96:2034-42.
93. Van Meter CH, Claycomb WC, Delcarpio JB, et al. Myoblast transplantation in the porcine model, a potential technique for myocardial repair. J Thorac Cardiovas Surg 1995;110:1442-8.
94. Scorsin M, Marotte F, Sabri A, et al. Can grafted cardiomyocytes colonize peri-infarct myocardial areas? Circulation 1996;94:II337-40.
95. Leor L, Patterson M, Quinones MJ, Kedes LH, Kloner RK. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat: a potential method for repair of infarcted myocardium? Circulation 1996;94:II332-6.
96. Li R-K, Jia Z-Q, Weisel RD, et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 1996;62:654-61.
97. Li R-K, Mickle DAG, Weisel RD, et al. The natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation 1997;96:II179-87.